Akoya Biosciences, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product
Service and other
Total revenue
Cost of goods sold
Product
Service and other
Total cost of goods sold
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Change in fair value of contingent consideration
Depreciation and amortization
Impairment
Restructuring
Total operating expenses
Loss from operations
Other income (expense):
Interest expense
Change in fair value of warrant liability
Gain on extinguishment of debt
Interest income
Other expense, net
Loss before provision for income taxes

Provision for income taxes
Net loss
Dividends accrued on redeemable convertible preferred stock
Adjusted net loss attributable to common stockholders
Net loss per share attributable to common stockholders, basic
Net loss per share attributable to common stockholders, diluted
Weighted-average shares outstanding, basic
Weighted-average shares outstanding, diluted

Comments